| 3.045 0.055 (1.84%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.72 | 1-year : | 4.06 |
| Resists | First : | 3.18 | Second : | 3.48 |
| Pivot price | 3.08  |
|||
| Supports | First : | 2.72 | Second : | 2.26 |
| MAs | MA(5) : | 3.02 |
MA(20) : | 3.11 |
| MA(100) : | 2.88 |
MA(250) : | 2.48 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 28 |
D(3) : | 26.9 |
| RSI | RSI(14): 47.3 |
|||
| 52-week | High : | 3.5 | Low : | 1.79 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ RSSS ] has closed above bottom band by 33.6%. Bollinger Bands are 35.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.07 - 3.09 | 3.09 - 3.11 |
| Low: | 2.89 - 2.91 | 2.91 - 2.93 |
| Close: | 2.97 - 3 | 3 - 3.03 |
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
Tue, 23 Apr 2024
Research Solutions set to grow with new SaaS model, Buy rating initiated on stock by Lake Street By Investing.com - Investing.com Nigeria
Mon, 15 Apr 2024
Research Solutions Unveils AI Platform for Automated Clinical Trial Landscape Reports - InvestorsObserver
Sat, 06 Apr 2024
With 37% stake, Research Solutions, Inc. (NASDAQ:RSSS) seems to have captured institutional investors' interest - Yahoo Canada Finance
Thu, 14 Mar 2024
Take Care Before Diving Into The Deep End On Research Solutions, Inc. (NASDAQ:RSSS) - Simply Wall St
Tue, 05 Mar 2024
Should You Hold Research Solutions (RSSS)? - Yahoo Finance
Tue, 13 Feb 2024
How Does the Resolute AI Acquisition Impact Research Solutions (RSSS)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 33 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 24.8 (%) |
| Held by Institutions | 33.3 (%) |
| Shares Short | 41 (K) |
| Shares Short P.Month | 45 (K) |
| EPS | -0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.46 |
| Profit Margin | -1.1 % |
| Operating Margin | -4.1 % |
| Return on Assets (ttm) | -2.5 % |
| Return on Equity (ttm) | -4.4 % |
| Qtrly Rev. Growth | 18.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.24 |
| EBITDA (p.s.) | -0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -151.34 |
| PEG Ratio | 2 |
| Price to Book value | 6.43 |
| Price to Sales | 2.42 |
| Price to Cash Flow | 51.15 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|